spiderdesign80
About
Low-dose fludarabine as well as cyclophosphamide joined with rituximab inside the first-line treatments for elderly/comorbid sufferers with long-term lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL): long-term link between project Q-lite with the Czech CLL Research Group.